Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma

Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer, with intermediate biological characteristics between hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Given its rarity and the lack of robust data from randomized clinical trials, treatment is not stand...

Full description

Saved in:
Bibliographic Details
Main Authors: Chiara Deiana, Andrea Palloni, Mirta Mosca, Francesco Vasuri, Stefano Chillotti, Simona Tavolari, Dario De Biase, Giorgio Frega, Elisa Giovannetti, Giovanni Brandi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Oncology
Subjects:
combined hepatocellular-cholangiocarcinoma
TKI
immunotherapy
predictive tools
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1459705/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1459705/full

Similar Items